Olfactomedin 4 in cancer development and progression

Wenli Liu1, Griffin P Rodgers1

  • 1Molecular and Clinical Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA.

Insights

Olfactomedin 4 (OLFM4) plays key roles in cell functions and diseases, including cancer. Inhibiting OLFM4 may benefit certain cancers, and it shows potential as an early diagnostic biomarker.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Immunology

Background:

  • Olfactomedin 4 (OLFM4) is an endogenous protein found in human tissues.
  • It participates in cellular processes like proliferation, apoptosis, and adhesion.
  • OLFM4 is implicated in inflammation, infectious diseases, and various cancers.

Purpose of the Study:

  • To investigate the multifaceted roles of OLFM4 in human health and disease.
  • To explore OLFM4's context-dependent functions in cancer development and progression.
  • To evaluate OLFM4's potential as a therapeutic target and diagnostic biomarker.

Main Methods:

  • Analysis of OLFM4 expression patterns in normal and cancerous tissues.
  • Investigation of OLFM4's molecular mechanisms in cellular functions.
  • Review of existing literature on OLFM4's involvement in disease pathways.

Main Results:

  • OLFM4 exhibits context-dependent tumor-suppressing or tumor-promoting effects in different cancers.
  • Aberrant OLFM4 expression is observed in multiple human cancers via diverse mechanisms.
  • OLFM4's role varies based on tissue and cellular environment.

Conclusions:

  • Targeting OLFM4 expression could offer therapeutic benefits in cancers where it promotes tumor growth.
  • OLFM4 demonstrates potential as a biomarker for early detection of precancerous conditions.
  • Understanding OLFM4's dual role is crucial for developing effective cancer therapies.

Related Concept Videos

Olfaction01:25

Olfaction

The sense of smell is achieved through the activities of the olfactory system. It starts when an airborne odorant enters the nasal cavity and reaches olfactory epithelium (OE). The OE is protected by a thin layer of mucus, which also serves the purpose of dissolving more complex compounds into simpler chemical odorants. The size of the OE and the density of sensory neurons varies among species; in humans, the OE is only about 9-10 cm2.
The olfactory receptors are embedded in the cilia of the...
45.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Olfactory Receptors: Location and Structure01:03

Olfactory Receptors: Location and Structure

The process of olfaction, also known as the sense of smell, is a sophisticated chemical response system. The specialized sensory neurons that facilitate this process, known as olfactory receptor neurons, are situated in an upper segment of the nasal cavity, known as the olfactory epithelium. Olfactory sensory neurons are bipolar, with their dendrites extending from the epithelium's apex into the mucus that lines the nasal cavity. Airborne molecules, when inhaled, traverse the olfactory...
9.6K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.4K